Tongling Jieya Biologic Technology Co., Ltd. (SHE:301108)

China · Delayed Price · Currency is CNY

33.00

+0.03 (0.09%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Personal Products	547.45M	622.59M	666.56M	984.45M	743.01M
Personal Products Growth	-12.07%	-6.60%	-32.29%	32.49%	141.70%
Total	547.45M	622.59M	666.56M	984.45M	743.01M
Total Growth	-12.07%	-6.60%	-32.29%	32.49%	141.70%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	286.37M	335.58M	276.41M	256.17M	205.97M
China Growth	-14.67%	21.41%	7.90%	24.38%	41.52%
Foreign	261.08M	287.01M	390.15M	728.27M	537.04M
Foreign Growth	-9.03%	-26.44%	-46.43%	35.61%	234.46%
Total	547.45M	622.59M	666.56M	984.45M	743.01M
Total Growth	-12.07%	-6.60%	-32.29%	32.49%	142.73%

Source: S&P Global Market Intelligence.